Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

TBC-1269 enters clinical evaluation as inhaled therapy for asthma

June 27, 2001

Novel antiallergic agents in the Taisho pipeline

June 26, 2001

NicOx and Biolipox to codevelop NO-releasing respiratory therapies

June 26, 2001

Genentech returns rights to respiratory compounds to Inspire

June 22, 2001

Merck patents pyrrole-based PDE7/TNF-alpha production inhibitors

June 21, 2001

Candidate mucin production inhibitor presented at ATS 2001

June 19, 2001

BMS synthesizes wide series of PTK inhibitors

June 18, 2001

Mucoregulators identified at Genaera with potential in COPD

June 18, 2001

PDE4 inhibitors prepared at Byk Gulden may have therapeutic application in inflammation or ED

June 14, 2001

Yamanouchi presents stable, orally active PDE4 inhibitors

June 14, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...